Removing Barriers to Clinical Research Act of 2016
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 3, 2016)
Removing Barriers to Clinical Research Act of 2016
This bill amends title XVIII (Medicare) of the Social Security Act to expand Medicare coverage of costs associated with clinical trials. Under current law, Medicare covers routine costs of care furnished to a beneficiary enrolled in a category A (experimental) clinical trial of a medical device intended for use in the diagnosis, monitoring, or treatment of an immediately life-threatening disease or condition. The bill requires Medicare to also cover, with respect to a beneficiary enrolled in a category B (non-experimental) clinical trial, routine costs of care as well as the cost of the device under investigation.
A trial of a medical device shall, for purposes of Medicare coverage, be deemed to meet the definition of a category A or category B clinical trial, as the case may be, if the trial is conducted under the Federal Food, Drug, and Cosmetic Act's investigational use exemption.
What just happenedMar 9, 2016
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 3, 2016
- Mar 9, 2016Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 4, 2016Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 3, 2016IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Mar 3, 2016IntroReferralH11100-A
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 3, 2016IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Mar 3, 2016IntroReferralIntro-H
Introduced in House
- Mar 3, 2016IntroReferral1000
Introduced in House